Skip to main content
OpenTrials

Clinical trial condition

Hereditary Complement Deficiency Diseases

Explore clinical trials studying Hereditary Complement Deficiency Diseases. Study availability and eligibility vary by location and protocol.

145 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Hereditary Complement Deficiency Diseases trial results

Recruiting

Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency

NCT07266805

Conditions
Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH), Acquired angioedema, Angioedema, +15 more
Locations
  • Study Site San Diego, California, United States
  • Study Site Walnut Creek, California, United States
  • Study Site St Louis, Missouri, United States
  • Study Site Hershey, Pennsylvania, United States
View all 32 locations
View Trial Details
Recruiting

Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)

NCT07428499

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +17 more
Locations
  • ADARx Clinical Site Litchfield Park, Arizona, United States
  • ADARx Clinical Site Little Rock, Arkansas, United States
  • ADARx Clinical Site San Diego, California, United States
  • ADARx Clinical Site Walnut Creek, California, United States
View all 48 locations
View Trial Details
Recruiting

STOP-HAE: A Phase 3 Study of ADX-324 in HAE

NCT06960213

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +17 more
Locations
  • ADARx Clinical Site Litchfield Park, Arizona, United States
  • ADARx Clinical Site Little Rock, Arkansas, United States
  • ADARx Clinical Site San Diego, California, United States
  • ADARx Clinical Site Walnut Creek, California, United States
View all 51 locations
View Trial Details
Recruiting

A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)

NCT07001280

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Medical Research of Arizona Phoenix, Arizona, United States
  • Sirven and Associates Miami, Florida, United States
  • Asthma and Allergy Wellness Center Saint Charles, Illinois, United States
  • Family Allergy and Asthma Louisville, Kentucky, United States
View all 22 locations
View Trial Details
Recruiting

Donidalorsen Treatment in Children With Hereditary Angioedema

NCT07298447

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Ionis Investigative Site Santa Monica, California, United States
  • Ionis Investigative Site Miami, Florida, United States
  • Ionis Investigative Site St Louis, Missouri, United States
  • Ionis Investigative Site Cincinnati, Ohio, United States
View Trial Details
Recruiting

Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

NCT06679881

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Study Site Birmingham, Alabama, United States
  • Study Site Scottsdale, Arizona, United States
  • Study Site Little Rock, Arkansas, United States
  • Study Site San Diego, California, United States
View all 62 locations
View Trial Details
Recruiting

Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)

NCT06919003

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • Kansas University Medical Center Kansas City, Kansas, United States
  • Montefiore Medical Center The Bronx, New York, United States
View Trial Details

Related conditions